Intratympanic Corticosteroid Administration as a Primary Treatment for Idiopathic Sudden Sensorineural Hearing Loss

Indian J Otolaryngol Head Neck Surg. 2022 Aug;74(Suppl 1):72-73. doi: 10.1007/s12070-020-01831-y. Epub 2020 Mar 23.

Abstract

A retrospective review of 34 patients was done who had idiopathic sudden sensorineural hearing loss and were administered intratympanic corticosteroid in the form of dexamethasone (4 mg/ml). The results were interpreted based on pure tone audiometry and Speech discrimination score of the patient before commencing the treatment and after the treatment.

Keywords: 34 cases; Idiopathic sudden sensorineural hearingloss; Intratympanic corticosteroid.